Search

everythinglearnresearchcommunity

for

Search:↓

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Terbinafine can cause hair loss.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Cyclosporin doesn't stop hair loss.

Long-term exposure to benzene increases skin diseases, blood disorders, and liver problems.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The document suggests simplifying alopecia diagnosis and improving techniques for better accuracy.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Careful histologic examination is crucial to differentiate types of bullous lesions in cutaneous lupus erythematosus.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

G-CSF effectively treated a teenager's cyclic neutropenia and reduced her symptoms without adverse effects.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.